Gopalakrishnan, Ramakrishnan http://orcid.org/0000-0002-5068-6886
Matta, Hittu
Choi, Sunju
Natarajan, Venkatesh
Prins, Ruben
Gong, Songjie
Zenunovic, Arta
Narasappa, Nell
Patel, Fatima
Prakash, Rekha
Chaudhary, Vishan
Sikri, Varun
Chitnis, Saurabh Deepak
Kochegarov, Andrei
Wang, Dan
Falat, Magdalena
Kahn, Michael
Keerthipati, Pooja Smruthi
Sharma, Naman
Lenka, Jyotirmayee
Stieben, Tomas Meza
Braun, Jason
Batra, Ankita
Purvis, Katelyn
Ito, Kenta
Lee, Jae Han
Jeronimo, Alberto
Zamora, Hannalei Mae
Membreno, Allen
Qiu, Queenie
Peshin, Supriya
Namburu, Lalith
Chaudhary, Preet M.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research (R01DE025804)
Ming Hsieh Institute for Research of Engineering-Medicine for Cancer
Article History
Received: 13 August 2018
Accepted: 18 December 2018
First Online: 13 February 2019
Competing Interests
: P.M.C. is an inventor on a patent application related to the technology described in this manuscript. PMC serves as consultant for Athelas and Oncotartis and is the founder of Angeles Therapeutics. V.C. and V.S. are family relations of P.M.C. P.M.C., V.C., and V.S. declare no other competing interests.